291 related articles for article (PubMed ID: 23893243)
1. A novel 3p22.3 gene CMTM7 represses oncogenic EGFR signaling and inhibits cancer cell growth.
Li H; Li J; Su Y; Fan Y; Guo X; Li L; Su X; Rong R; Ying J; Mo X; Liu K; Zhang Z; Yang F; Jiang G; Wang J; Zhang Y; Ma D; Tao Q; Han W
Oncogene; 2014 Jun; 33(24):3109-18. PubMed ID: 23893243
[TBL] [Abstract][Full Text] [Related]
2. CMTM7 knockdown increases tumorigenicity of human non-small cell lung cancer cells and EGFR-AKT signaling by reducing Rab5 activation.
Liu B; Su Y; Li T; Yuan W; Mo X; Li H; He Q; Ma D; Han W
Oncotarget; 2015 Dec; 6(38):41092-107. PubMed ID: 26528697
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
[TBL] [Abstract][Full Text] [Related]
4. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
5. CMTM3, located at the critical tumor suppressor locus 16q22.1, is silenced by CpG methylation in carcinomas and inhibits tumor cell growth through inducing apoptosis.
Wang Y; Li J; Cui Y; Li T; Ng KM; Geng H; Li H; Shu XS; Li H; Liu W; Luo B; Zhang Q; Mok TS; Zheng W; Qiu X; Srivastava G; Yu J; Sung JJ; Chan AT; Ma D; Tao Q; Han W
Cancer Res; 2009 Jun; 69(12):5194-201. PubMed ID: 19509237
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
7. SOX10-dependent CMTM7 expression inhibits cell proliferation and tumor growth in gastric carcinoma.
Jin Y; Qin X; Jia G
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):91-99. PubMed ID: 30392914
[TBL] [Abstract][Full Text] [Related]
8. Induction of tumor inhibition and apoptosis by a candidate tumor suppressor gene DRR1 on 3p21.1.
Liu Q; Zhao XY; Bai RZ; Liang SF; Nie CL; Yuan Z; Wang CT; Wu Y; Chen LJ; Wei YQ
Oncol Rep; 2009 Nov; 22(5):1069-75. PubMed ID: 19787223
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tumor suppressive function of P300/CBP-associated factor at frequently deleted region 3p24 in esophageal squamous cell carcinoma.
Zhu C; Qin YR; Xie D; Chua DT; Fung JM; Chen L; Fu L; Hu L; Guan XY
Oncogene; 2009 Aug; 28(31):2821-8. PubMed ID: 19525977
[TBL] [Abstract][Full Text] [Related]
10. CMTM3 inhibits cell growth and migration and predicts favorable survival in oral squamous cell carcinoma.
Zhang H; Zhang J; Nan X; Li X; Qu J; Hong Y; Sun L; Chen Y; Li T
Tumour Biol; 2015 Sep; 36(10):7849-58. PubMed ID: 25946973
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a candidate tumor suppressor gene uroplakin 1A in esophageal squamous cell carcinoma.
Kong KL; Kwong DL; Fu L; Chan TH; Chen L; Liu H; Li Y; Zhu YH; Bi J; Qin YR; Law SY; Guan XY
Cancer Res; 2010 Nov; 70(21):8832-41. PubMed ID: 20978196
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase receptor type {gamma} is a functional tumor suppressor gene specifically downregulated in chronic myeloid leukemia.
Della Peruta M; Martinelli G; Moratti E; Pintani D; Vezzalini M; Mafficini A; Grafone T; Iacobucci I; Soverini S; Murineddu M; Vinante F; Tecchio C; Piras G; Gabbas A; Monne M; Sorio C
Cancer Res; 2010 Nov; 70(21):8896-906. PubMed ID: 20959494
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
[TBL] [Abstract][Full Text] [Related]
14. Change of CMTM7 expression, a potential tumor suppressor, is associated with poor clinical outcome in human non-small cell lung cancer.
Liu Q; Su Y; Jiang GC; Zhou ZL; Liu BC; Bu L; Yang F; Qiao F; Wang J
Chin Med J (Engl); 2013 Aug; 126(16):3006-12. PubMed ID: 23981602
[TBL] [Abstract][Full Text] [Related]
15. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
18. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
[TBL] [Abstract][Full Text] [Related]
19. CMTM3 is reduced in prostate cancer and inhibits migration, invasion and growth of LNCaP cells.
Hu F; Yuan W; Wang X; Sheng Z; Yuan Y; Qin C; He C; Xu T
Clin Transl Oncol; 2015 Aug; 17(8):632-9. PubMed ID: 25990505
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase C delta 1 is a novel 3p22.3 tumor suppressor involved in cytoskeleton organization, with its epigenetic silencing correlated with high-stage gastric cancer.
Hu XT; Zhang FB; Fan YC; Shu XS; Wong AH; Zhou W; Shi QL; Tang HM; Fu L; Guan XY; Rha SY; Tao Q; He C
Oncogene; 2009 Jul; 28(26):2466-75. PubMed ID: 19448674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
